Meline David W 4
4 · Moderna, Inc. · Filed Feb 11, 2021
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Meline David W
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-09+25,618→ 25,618 totalExercise: $179.52From: 2022-02-09Exp: 2031-02-09→ Common Stock (25,618 underlying) - Award
Restricted Stock Units
2021-02-09+5,570→ 5,570 totalExercise: $0.00From: 2022-02-09→ Common Stock (5,570 underlying)
Footnotes (2)
- [F1]25% of this option will vest and become exercisable on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to this restricted stock unit award will vest on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.